![Glenmark Pharmaceuticals Limited logo](/logos/GLENMARK.NS.webp)
Glenmark Pharmaceuticals Limited
NSE:GLENMARK.NS
Overview | Financials
Company Name | Glenmark Pharmaceuticals Limited |
Symbol | GLENMARK.NS |
Currency | INR |
Price | 1,702.7 |
Market Cap | 480,481,507,600 |
Dividend Yield | 0.25% |
52-week-range | 722.1 - 1,750.5 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Glenn Mario Saldanha |
Website | https://www.glenmarkpharma.com |
An error occurred while fetching data.
About Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, and internationally. The company provides branded and generic formulations in the therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes ISB 830 (telazorlimab),
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD